Term ended Dec 5, 2025 · Medium confidence
20-year base term ended Dec 5, 2025
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,713,266), so the cap could be lower.
Dec 5, 2005
Dec 5, 2025
Jan 4, 2011
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 5, 2005, when application 11/295,204, the earliest non-provisional in its chain, was filed (this one was filed Mar 6, 2009) | Dec 5, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,713,266) | resolves to Dec 5, 2025, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Dec 5, 2025 | Medium confidence |
This family
| US 7,713,266 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 7,850,683 | Term ended no later than Oct 2026 | no later than Oct 2026 |
| US 7,862,558 | this patent Dec 2025 | Dec 2025 |
| US 7,998,137 | Term ended no later than Dec 2025 | no later than Dec 2025 |
| US 9,072,498 | Term ended Dec 2025 | Dec 2025 |
| US 9,345,526 | Term ended Dec 2025 | Dec 2025 |
| US 10,363,080 | Term ended Dec 2025 | Dec 2025 |
| US 11,963,706 | In force no later than Aug 2029 | no later than Aug 2029 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 8, 2010 Reel 25116, frame 787 | Elkins, Lisa; Williams, Ronald | Myoscience, Inc. | Assignment of Assignor's Interest |
| Dec 19, 2014 Reel 34557, frame 73 | Myoscience, Inc. | Venture Lending & Leasing VII, Inc. | Security Interest |
| Dec 29, 2014 Reel 34713, frame 226 | Myoscience, Inc. | Venture Lending & Leasing VII, Inc. | Corrective Assignment to Correct to Remove Application Number 12160639 Previously Recorded at Reel: 034557 Frame: 0073. Assignor(S) Hereby Confirms the Security Agreement. |
| Feb 4, 2019 Reel 48237, frame 168 | Venture Lending & Leasing VII, Inc. | Myoscience, Inc. | Release of Security Interest |
| Jul 15, 2019 Reel 49758, frame 28 | Myoscience, Inc. | Pacira Cryotech, Inc. | Confirmatory Assignment |
| Dec 14, 2021 Reel 58516, frame 636 | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Flexion Therapeutics, Inc. | Jpmorgan Chase Bank, N.a. | Supplemental Confirmatory Grant of Security Interest in United States Patents |
| Mar 31, 2023 Reel 63213, frame 864 | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Termination and Release of Security Interest in Patents |
| Mar 31, 2023 Reel 63214, frame 108 | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Jpmorgan Chase Bank, N.a. | Confirmatory Grant of Security Interest in United States Patents |
| Mar 31, 2023 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc. | Termination and Release of Security Interest in Patents |
| Mar 31, 2023 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Pharmaceuticals, Inc. | Termination and Release of Security Interest in Patents |
| Mar 31, 2023 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Termination and Release of Security Interest in Patents |
| Dec 5, 2025 Reel 73779, frame 532 | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Pharmaceuticals, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,713,266, ends no earlier than this term, so it caps nothing.